HFE C282Y and H63D in adults with malignancies in a community medical oncology practice [PDF]
, 2004 James C. Barton +2 more
openalex +1 more source
Molecular Oncology, EarlyView.This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain +3 more
wiley +1 more source
European CME in oncology progresses; recognition of medical oncology less so
, 1995 Theo Wagener
openalex +1 more source
European Society of Medical Oncology membership survey [PDF]
, 2004 Heinz Ludwig
openalex +1 more source
Interplay of integrins and selectins in metastasis
Molecular Oncology, EarlyView.Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva +2 more
wiley +1 more source
Implementing Ryan's Law on an Inpatient Medical Oncology Unit. [PDF]
Clin J Oncol NursMcKaig A +4 more
europepmc +1 more source
Patterns and outcome of unplanned care in lung cancer patients: an observational study in a medical oncology department. [PDF]
Transl Lung Cancer Res, 2023 Sánchez JC +9 more
europepmc +1 more source
9th Symposium and Annual Meeting of Croatian Society for Medical Oncology of Croatian Medical Association with International Participation and 11th Meeting of Oncology Pharmacy Section of Croatian Pharmaceutical Society with International Participation [PDF]
, 2017 Croatian Society for Medical Oncology, Croatian Medical Association +1 more
core +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Molecular Oncology, EarlyView.Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson +11 more
wiley +1 more source